Minimally invasive structural heart implants are moving from mitral into tricuspid valve repair, as well as mitral valve replacement. Abbott Laboratories is presenting its latest data on all these fronts at the virtual PCR e-Course held by the European Association of Percutaneous Cardiovascular Interventions from June 25 to 27. Read More
Conventional wisdom has it that recent expansions in coverage of telehealth will never be fully reversed. The addition of artificial intelligence (AI) into telehealth could solve several issues faced by doctors and hospitals. There is some concern, however, that the blending of AI and telehealth will industrialize the practice of medicine, dissuading patients from seeking critically needed care. Read More
Thermo Fisher Scientific Inc. is working with Daiichi Sankyo Co. Ltd. to develop a companion diagnostic (CDx) to identify non-small-cell lung cancer (NSCLC) patients with human epidermal growth factor receptor 2 (HER2) mutations who could be eligible for the Tokyo-based company's cancer drug, Enhertu. Read More
Elixir Medical Corp., reported positive 12-month results for its Dynamx Coronary Bioadaptor System, with no target vessel revascularization (TVR) or stent thrombosis and adaptive remodeling of the artery to sustain healthy blood flow. The findings, from a multisite European trial, were presented during a late-breaking trials session at the PCR e-Course virtual meeting in Paris. Read More
TORONTO – Once he’d enrolled in an entrepreneurial engineering course, third-year medical school student Gabriel Georges’ task was deceptively simple: come up with a device to meet an unmet medical need. Before long, Georges had pulled two other students with engineering and investor relations smarts into the project, developing a minimally invasive, long-term transcatheter heart pump that this month garnered financing from Canadian and U.S. investors. Read More
PARIS – Orixha SAS is developing new pulmonary ventilation technology for critical care scenarios. “Our total liquid ventilator could be of benefit through its ultra-fast ability to cool the vital organs of patients in cardiac arrest,” Fabrice Paublant, CEO of Orixha, told BioWorld. The aim is to improve survival rates and reduce the neurological complications of postcardiac arrest syndrome. Read More
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Biocartis, Intact Vascular, Neovasc, Royal Philips. Read More
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Anyplace MD, Applied DNA Sciences, Biocodex, Biocodex Microbiota Foundation, Biostem, Brainlab, Device Access UK, Intersect ENT, Nexstim, Phunware, Venus Concept. Read More
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Masimo. Read More
Keeping you up to date on recent developments in neurology, including: A focused approach to imaging neural activity in the brain; International study discovers 3 potential new targets for treating epilepsy; New genetic mutations linked to ASD; Alzheimer’s study finds higher risk of disease in women vs. men due to hormones. Read More
